Neogen (NEOG) Net Cash Flow (QoQ) (2010 - 2026)
Neogen (NEOG) Net Cash Flow (QoQ) (2010 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - |
| 10 | Neogen | 2.09 Bn | 1.93 Bn | 99.00 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Feb 28, 2026 | 62.36% |
| Nov 30, 2025 | -20.26% |
| Aug 31, 2025 | 692.96% |
| May 31, 2025 | 87.19% |
| Feb 28, 2025 | -155.75% |
| Nov 30, 2024 | 142.86% |
| Aug 31, 2024 | -653.40% |
| May 31, 2024 | 120.97% |
| Feb 29, 2024 | -261.83% |
| Nov 30, 2023 | 75.08% |
| Aug 31, 2023 | -84.31% |
| May 31, 2023 | 361.42% |
| Feb 28, 2023 | -652.72% |
| Nov 30, 2022 | -107.29% |
| Aug 31, 2022 | 2,923.87% |
| May 31, 2022 | 129.87% |
| Feb 28, 2022 | 52.43% |
| Nov 30, 2021 | -1,285.47% |
| Aug 31, 2021 | -214.67% |
| May 31, 2021 | 102.56% |